Status
Conditions
Treatments
About
The overall aim of the study is to determine effects of different meal characteristics on energy intake, eating rate and appetite.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Food allergies, intolerances or preferences preventing consumption of any products included in the study.
Unable to sufficiently understand written and spoken Swedish or English to provide written consent and understand information and instructions from the study personal.
Pregnant, lactating or planning a pregnancy during the study period.
History of stomach or gastrointestinal conditions or major gastrointestinal surgery (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
Type 1 diabetes or type 2 diabetes.
Drug treated thyroid disorder
•- Following any weight reduction program or having followed one during the last 6 months prior to screening.
Medication for weight reduction purpose effecting appetite or fat absorption (e.g. GLP-1 analogues, orlistat)
Severe dysfunctional eating behavior based on Three Factor Eating Questionnaire
Primary purpose
Allocation
Interventional model
Masking
85 participants in 4 patient groups
Loading...
Central trial contact
Therese Karlsson, PhD; Linnea Bärebring, PhD, Associate professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal